Targeting the NLRP3 inflammasome to reduce diet-induced metabolic abnormalities in mice

Molecular Medicine

Volumn 21, Issue , 2015, Pages 1025-1037

  Chiazza, Fausto ^a   Couturier Maillard, Aurélie ^b   Benetti, Elisa ^a   Mastrocola, Raffaella ^a   Nigro, Debora ^a   Cutrin, Juan C ^a,c   Serpe, Loredana ^a   Aragno, Manuela ^a   Fantozzi, Roberto ^a   Ryffel, Bernard ^b   Thiemermann, Christoph ^d   Collino, Massimo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CHOLESTEROL; CRYOPYRIN; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN; I KAPPA B; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BIOCHEMICAL ANALYSIS; CALORIC INTAKE; CARBOHYDRATE DIET; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; DYSLIPIDEMIA; ENZYME INHIBITION; FATTY LIVER; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GENE SILENCING; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION; KIDNEY INJURY; LIPID DIET; LIPID STORAGE; LIVER; LIVER INJURY; MALE; METABOLIC DISORDER; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OLIGOMERIZATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; UPREGULATION; WEIGHT GAIN; WESTERN BLOTTING;

EID: 84975141182     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.2119/molmed.2015.00104     Document Type: Article

References (46)

1. Calay ES, Hotamisligil GS. (2013) Turning off the inflammatory, but not the metabolic, flames. Nat. Med. 19:265-7.
2. Donath MY. (2014) Targeting inflammation in the treatment of type 2 diabetes: Time to start. Nat. Rev. Drug. Discov. 13:465-76.
3. Tabas I, Glass CK. (2013) Anti-inflammatory therapy in chronic disease: Challenges and opportunities. Science. 339:166-72.
4. Tack CJ, Stienstra R, Joosten LA, Netea MG. (2012) Inflammation links excess fat to insulin resistance: The role of the interleukin-1 family. Immunol. Rev. 249:239-52.
5. Schroder K, Tschopp J. (2010) The inflammasomes. Cell. 140:821-32.
6. Benetti E, Chiazza F, Patel NS, Collino M. (2013) The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. Mediators Inflamm. 2013:678627.
7. Wen H, et al. (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12:408-15.
8. Duewell P, et al. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 464:1357-61.
9. Vandanmagsar B, et al. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17:179-88.
10. Stienstra R, et al. (2010) The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell. Metab. 12:593-605.
11. Reynolds CM, et al. (2012) Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Mol. Nutr. Food Res. 56:1212-22.
12. Collino M, et al. (2013) Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-δ agonism correlates with impaired NLRP3 inflammasome activation. Biochem. Pharmacol. 85:257-64.
13. Stienstra R, et al. (2011) Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 108:15324-9.
14. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 440:237-41.
15. Kumar A, Negi G, Sharma SS. (2012) Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie. 94:1158-65.
16. Bustin SA, et al. (2009) The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55:611-22.
17. Collino M, et al. (2014) A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice. Br. J. Pharmacol. 171:5802-15.
18. Goossens GH, et al. (2012) Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans. Mol. Immunol. 50:142-9.
19. Lee HM, et al. (2013) Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 62:194-204.
20. Wang C, Pan Y, Zhang QY, Wang FM, Kong LD. (2012) Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One. 7:e38285.
21. Yang SJ, Lim Y. (2014) Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation. Metabolism. 63:693-701.
22. Honda H, et al. (2014) Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J. Leukoc. Biol. 96:1087-100.
23. Shan Q, et al. (2014) Purple sweet potato color ameliorates kidney damage via inhibiting oxidative stress mediated NLRP3 inflammasome activation in high fat diet mice. Food Chem. Toxicol. 69:339-46.
24. Juliana C, et al. (2010) Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome. J. Biol. Chem. 285:9792-802.
25. Taniguchi CM, Emanuelli B, Kahn CR. (2006) Critical nodes in signalling pathways: Insights into insulin action. Nat. Rev. Mol. Cell. Biol. 7:85-96.
26. Bouzakri K, et al. (2006) siRNA-based gene silencing reveals specialized roles of IRS-1/ Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell. Metab. 4:89-96.
27. Leto D, Saltiel AR. (2012) Regulation of glucose transport by insulin: Traffic control of GLUT4. Nat. Rev. Mol. Cell. Biol. 13:383-96.
28. Zeng XQ, et al. (2012) Knockdown of NYGGF4 increases glucose transport in C2C12 mice skeletal myocytes by activation IRS-1/PI3K/ AKT insulin pathway. J. Bioenerg. Biomembr. 44:351-55.
29. Semple RK, et al. (2009) Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J. Clin. Invest. 119:315-22.
30. Boini KM, et al. (2014) Activation of inflammasomes in podocyte injury of mice on the high fat diet: Effects of ASC gene deletion and silencing. Biochim. Biophys. Acta. 1843:836-45.
31. Dattaroy D, et al. (2015) Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 308:G298-312.
32. Lan HY, Chung AC. (2012) TGF-beta/Smad signaling in kidney disease. Sem. Nephrol. 32:236-43.
33. Nomura M, et al. (2014) SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity. Diabetologia. 57:157-66.
34. Velayudham A, et al. (2009) VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology. 49:989-97.
35. Witek RP, et al. (2009) Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Hepatology. 50:1421-30.
36. Chen GY, Nuñez G. (2010) Sterile inflammation: Sensing and reacting to damage. Nat. Rev. Immunol. 10:826-37.
37. Lamkanfi M. (2011) Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 11:213-20.
38. Vilaysane A, et al. (2010) The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J. Am. Soc. Nephrol. 21:1732-44.
39. Solini A, et al. (2013) The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: Possible role of NLRP3 inflammasome activation. J. Pathol. 231:342-53.
40. Csak T, et al. (2011) Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology. 54:133-44.
41. Wree A, et al. (2014) NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology. 59:898-910.
42. Lee J, Rhee MH, Kim E, Cho JY. (2012) BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets. Mediators Inflamm. 2012:416036.
43. Arkan MC, et al. (2005) IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11:191-8.
44. Dupaul-Chicoine J, et al. (2010) Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity. 32:367-78.
45. Hirota SA, et al. (2011) NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm. Bowel Dis. 17:1359-72.
46. Ridaura VK, et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 341:1241214.